Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
March-2015 Volume 11 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2015 Volume 11 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Soluble P‑selectin promotes acute myocardial infarction onset but not severity

  • Authors:
    • Ling Guo
    • Guizhi Sun
    • Guoyu Wang
    • Wenhu Ning
    • Kan Zhao
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Pharmacy, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China, Department of Emergency, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
  • Pages: 2027-2033
    |
    Published online on: November 10, 2014
       https://doi.org/10.3892/mmr.2014.2917
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

P‑selectin, an integral membrane glycoprotein of platelets and endothelial cells, and the soluble form of P‑selectin are hypothesized to play a role in the initiation of atherosclerosis and acute myocardial infarction (AMI). However, limited data are available with which to evaluate the main role of soluble P‑selectin (sP‑selectin) in the onset or the severity of AMI. In the present study, we investigated 15 patients who suffered from angina, 10 patients who underwent percutaneous coronary intervention (PCI) therapy and 10 patients who underwent thrombolysis therapy, compared with 15 volunteers with no cardiovascular disease. We confirmed that the plasma sP‑selectin levels were increased in patients with obesity (particularly pericardial obesity) and hyperlipidemia, positively correlated with plasma tumor necrosis factor (TNF)‑α and strongly negatively correlated with adiponectin in all patients regardless of AMI status. Furthermore, sP‑selectin levels were significantly higher in PCI and thrombolysis patients compared with angina patients and the control cohort. However, we observed that sP‑selectin levels did not change following PCI and thrombolysis therapy. In addition, there was no correlation between sP‑selectin levels and the severity of AMI in the cohort which received PCI or thrombolysis therapy. Therefore, we deduced that sP‑selectin only induced the onset of AMI but did not promote its severity. To confirm this hypothesis, a P‑selectin inhibitor was administered to an atherosclerosis formation model, plaque rapture model and neointimal hyperplasia model. We revealed that atherosclerotic plaque formation and rupture, neointimal formation and neointimal bleeding were suppressed by the sP‑selectin inhibitor. We concluded that sP‑selectin, induced by systemic inflammation in conditions including obesity and hyperlipidemia, promoted atherosclerotic plaque and neointimal formation, plaque rapture and neointimal bleeding, further leading to AMI. We also demonstrated that sP‑selectin had no effect on the severity of AMI.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Geng JG, Chen M and Chou KC: P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Curr Med Chem. 11:2153–2160. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Polek A, Sobiczewski W and Matowicka-Karna J: P-selectin and its role in some diseases. Postepy Hig Med Dosw (Online). 63:465–470. 2009.

3 

Yang J, Furie BC and Furie B: The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thromb Haemost. 81:1–7. 1999.PubMed/NCBI

4 

Blann AD, Nadar SK and Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 24:2166–2179. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Ramacciotti E, Blackburn S, Hawley AE, et al: Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost. 17:425–431. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Woollard KJ and Chin-Dusting J: P-selectin antagonism in inflammatory disease. Curr Pharm Des. 16:4113–4118. 2010. View Article : Google Scholar

7 

Burke AP and Virmani R: Pathophysiology of acute myocardial infarction. Med Clin North Am. 91:553–572. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Woollard KJ and Chin-Dusting J: Therapeutic targeting of p-selectin in atherosclerosis. Inflamm Allergy Drug Targets. 6:69–74. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Aversano T, Aversano LT, Passamani E, et al: Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 287:1943–1951. 2002. View Article : Google Scholar : PubMed/NCBI

10 

Ferroni P, Basili S, Martini F, et al: Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investig Med. 48:21–27. 2000.PubMed/NCBI

11 

Ertenli I, Kiraz S, Arici M, et al: P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. J Rheumatol. 25:1054–1058. 1998.PubMed/NCBI

12 

Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K and Kishimoto S: Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis. Clin Immunol. 131:495–500. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Konishi M, Sugiyama S, Sugamura K, et al: Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis. 209:573–578. 2010. View Article : Google Scholar

14 

Zhou J, Lhotak S, Hilditch BA and Austin RC: Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 111:1814–1821. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Johnson JL and Jackson CL: Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis. 154:399–406. 2001. View Article : Google Scholar : PubMed/NCBI

16 

Sata M, Maejima Y, Adachi F, et al: A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 32:2097–2104. 2000. View Article : Google Scholar : PubMed/NCBI

17 

Phillips JW, Barringhaus KG, Sanders JM, et al: Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 107:2244–2249. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Lin WY, Lee LT, Chen CY, et al: Optimal cut-off values for obesity: using simple anthropometric indices to predict cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord. 26:1232–1238. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Guo L, Ning W, Tan Z, Gong Z and Li X: Mechanism of matrix metalloproteinase axis-induced neointimal growth. J Mol Cell Cardiol. 66:116–125. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Konishi M, Sugiyama S, Sato Y, et al: Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 213:649–655. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Hamminga EA, van der Lely AJ, Neumann HA and Thio HB: Chronic inflammation in psoriasis and obesity: implications for therapy. Med Hypotheses. 67:768–773. 2006. View Article : Google Scholar : PubMed/NCBI

22 

Hackam DG and Anand SS: Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 290:932–940. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Quarck R, De Geest B, Stengel D, et al: Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice. Circulation. 103:2495–2500. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Merten M and Thiagarajan P: P-selectin in arterial thrombosis. Z Kardiol. 93:855–863. 2004. View Article : Google Scholar : PubMed/NCBI

25 

Hong MK, Mintz GS, Lee CW, et al: Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 110:928–933. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Lee SG, Lee CW, Hong MK, Kim JJ, Park SW and Park SJ: Change of multiple complex coronary plaques in patients with acute myocardial infarction: a study with coronary angiography. Am Heart J. 147:281–286. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Finn AV, Nakano M, Narula J, Kolodgie FD and Virmani R: Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 30:1282–1292. 2010. View Article : Google Scholar : PubMed/NCBI

28 

Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H and Vrints CJ: Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 99:1972–1977. 1999. View Article : Google Scholar : PubMed/NCBI

29 

Triant VA, Lee H, Hadigan C and Grinspoon SK: Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 92:2506–2512. 2007. View Article : Google Scholar : PubMed/NCBI

30 

Rosengren A, Wallentin L, Simoons M, et al: Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart. 91:1141–1147. 2005. View Article : Google Scholar : PubMed/NCBI

31 

Kvasnicka T, Kvasnicka J, Ceska R, Grauova B and Vrablik M: Increasing plasma levels of soluble cell adhesion molecules (sE-selectin, sP-selectin and sICAM-1) in overweight adults with combined hyperlipidemia. Sb Lek. 102:473–477. 2001.

32 

De Pergola G, Pannacciulli N, Coviello M, et al: sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis. 18:227–232. 2008. View Article : Google Scholar

33 

Larsson PT, Hallerstam S, Rosfors S and Wallen NH: Circulating markers of inflammation are related to carotid artery atherosclerosis. Int Angiol. 24:43–51. 2005.PubMed/NCBI

34 

Yngen M, Ostenson CG, Hu H, Li N, Hjemdahl P and Wallen NH: Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia. 47:537–540. 2004. View Article : Google Scholar : PubMed/NCBI

35 

Gokulakrishnan K, Deepa R, Mohan V and Gross MD: Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome - the Chennai Urban Rural Epidemiology Study. Metabolism. 55:237–242. 2006. View Article : Google Scholar : PubMed/NCBI

36 

Xu DY, Zhao SP and Peng WP: Elevated plasma levels of soluble P-selectin in patients with acute myocardial infarction and unstable angina. An inverse link to lipoprotein(a). Int J Cardiol. 64:253–258. 1998. View Article : Google Scholar : PubMed/NCBI

37 

Atalar E, Aytemir K, Haznedaroglu I, et al: Increased plasma levels of soluble selectins in patients with unstable angina. Int J Cardiol. 78:69–73. 2001. View Article : Google Scholar : PubMed/NCBI

38 

Eberini I, Gianazza E, Breghi L, et al: Apolipoprotein A-I breakdown is induced by thrombolysis in coronary patients. Ann Med. 39:306–311. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Guo L, Sun G, Wang G, Ning W and Zhao K: Soluble P‑selectin promotes acute myocardial infarction onset but not severity. Mol Med Rep 11: 2027-2033, 2015.
APA
Guo, L., Sun, G., Wang, G., Ning, W., & Zhao, K. (2015). Soluble P‑selectin promotes acute myocardial infarction onset but not severity. Molecular Medicine Reports, 11, 2027-2033. https://doi.org/10.3892/mmr.2014.2917
MLA
Guo, L., Sun, G., Wang, G., Ning, W., Zhao, K."Soluble P‑selectin promotes acute myocardial infarction onset but not severity". Molecular Medicine Reports 11.3 (2015): 2027-2033.
Chicago
Guo, L., Sun, G., Wang, G., Ning, W., Zhao, K."Soluble P‑selectin promotes acute myocardial infarction onset but not severity". Molecular Medicine Reports 11, no. 3 (2015): 2027-2033. https://doi.org/10.3892/mmr.2014.2917
Copy and paste a formatted citation
x
Spandidos Publications style
Guo L, Sun G, Wang G, Ning W and Zhao K: Soluble P‑selectin promotes acute myocardial infarction onset but not severity. Mol Med Rep 11: 2027-2033, 2015.
APA
Guo, L., Sun, G., Wang, G., Ning, W., & Zhao, K. (2015). Soluble P‑selectin promotes acute myocardial infarction onset but not severity. Molecular Medicine Reports, 11, 2027-2033. https://doi.org/10.3892/mmr.2014.2917
MLA
Guo, L., Sun, G., Wang, G., Ning, W., Zhao, K."Soluble P‑selectin promotes acute myocardial infarction onset but not severity". Molecular Medicine Reports 11.3 (2015): 2027-2033.
Chicago
Guo, L., Sun, G., Wang, G., Ning, W., Zhao, K."Soluble P‑selectin promotes acute myocardial infarction onset but not severity". Molecular Medicine Reports 11, no. 3 (2015): 2027-2033. https://doi.org/10.3892/mmr.2014.2917
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team